Arizona Tribune - Boulevard

Helicopter crash that killed Leicester City owner ruled an accident

The helicopter crash that killed the owner of Premier League football club Leicester City was an accident, an inquest jury ruled on Tuesday.

Nepal resumes rescue helicopter flights to Mount Everest

Nepali airlines have resumed rescue helicopter flights to the Everest region, an aviation industry official announced Tuesday, following weeks of suspension prompted by protests from locals citing environmental impact and loss of income from trekkers.

Fast-moving fires torch national parks in southeast Australia

Firefighters were desperately trying to stop a cluster of fast-moving blazes in southeast Australia on Tuesday, as thousands of acres of national park burned and a farming community was forced to evacuate.

Dermata Expands Patent Portfolio with Issuance of New U.S. Patent for Next-Generation Acne Treatment

- This is Dermata's first issued U.S. patent for XYNGARI™, which uses its Spongilla technology to topically treat acne -- Dermata expects to announce topline results from its STAR-1 Phase 3 XYNGARI™ clinical trial in March 2025 -- Over 30 million acne patients seek treatment in the U.S. each year, with topical products being first-line therapy -

Creator Economy Spotlighted at the 2025 NAB Show Featuring Headliner Dhar Mann, Top Digital Scripted Content Creator

Expanded Creator Lab to include more tools and content for the creator economy.

SkinCeuticals Announces Opening of SkinCeuticals SkinLab Honolulu in Ala Moana Center

SkinCeuticals Provides State-of-the-Art Skincare to Consumers in the Largest Open Air Shopping Center in the World

Leading Fashion Wholesale Events MAGIC, PROJECT and SOURCING at MAGIC, Return to Las Vegas for the Upcoming Market Season

Bringing together the men's, women's and sourcing fashion communities together, Las Vegas continues to be the destination for brands, buyers and attendees to collaborate and spark innovations

Cosmos Health Secures Bond Loan from European Bank on Very Competitive Terms, with Option to Upsize to Support Growth and Achieve Positive Operating Cash Flow

CHICAGO, IL / ACCESS Newswire / January 28, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that, on January 27, 2025, its wholly owned subsidiary, CosmoFarm S.A. (the "Issuer" or "CosmoFarm"), entered into an agreement with a European bank to issue a €2,200,000 (approximately $2,293,830) secured bond (the "Loan").

More than 50 Years of World of Concrete Drives Global Innovation to Empower the Workforce

The world's largest concrete construction and masonry tradeshow encompasses the future of building through leadership and education, integrating technology, solutions and partnerships.

UTMD Reports Year 2024 and Fourth Quarter Financial Performance

SALT LAKE CITY, UT / ACCESS Newswire / January 28, 2025 / With Revenues 19% lower, Net Income 17% lower and Earnings Per Share (EPS) 13% lower than in 2023, Utah Medical Products, Inc. (NASDAQ:UTMD) concluded a year of contraction. UTMD's stock price declined 27%, more than twice the EPS decline, which allowed the Company an opportunity to repurchase more than 8% of its shares in the open market.

Dolphin Subsidiary the Digital Dept. Launches New Division for Affiliate Marketing and Content Creator Services

LOS ANGELES, CA / ACCESS Newswire / January 28, 2025 / The Digital Dept., a leading influencer marketing agency and a subsidiary of Dolphin (NASDAQ:DLPN), announces the launch of its new Affiliate Marketing and Content Creator Services division. Tapping into the booming $13 billion affiliate marketing industry, this exciting expansion is designed to empower creators by providing them with innovative tools and strategies to elevate their earnings and grow their businesses.

DirectTrust(R) Seeks Nominations for New Board Directors

Nominees for three-year term sought from constituencies reflecting organization's diverse membership

Michael Weydemuller Promoted to Chief Compliance Officer at Spirits Capital Corporation

SCOTTSDALE, AZ / ACCESS Newswire / January 28, 2025 / Spirits Capital Corporation, a fintech company that seamlessly integrates technology with the global production, management, and transactional needs of the barrel-aged spirits market and the creator the Distilled Barrels Financial Exchange DBFEX™, announces the promotion of Michael Weydemuller to Chief Compliance Officer. In this expanded role, Michael will leverage his deep expertise in taxation and regulatory compliance to ensure that all transactions on Spirits Capital's flagship platform, the Distilled Barrels Financial Exchange (DBFEX™), are fully aligned with the stringent requirements set forth by the Alcohol, Tobacco Tax and Trade Bureau.

Lakeland Fire + Safety Awarded National Contract for Emergency Medical, Safety and Rescue Equipment through the HGACBuy Program

9,000+ Government Entities Able to Procure Lakeland's Product Portfolio through the HGACBuy Program

The Now Corporation (OTC:NWPN), Utilizing Its Subsidiary Green Rain Solar Inc., Advances EV Infrastructure in Rochester, NY

PASADENA, CA / ACCESS Newswire / January 28, 2025 / The Now Corporation, through its renewable energy subsidiary Green Rain Solar Inc., is making significant progress in enhancing electric vehicle (EV) infrastructure in disadvantaged communities across the United States. The company is pleased to announce that it has completed a utility feasibility study for its flagship project at 1600 West Ridge Road in Rochester, New York, clearing the way to move forward with installation plans.

Telomir Pharmaceuticals Announces Breakthrough Results With Telomir-1 Fully Reversing Oxidative Stress in Human Cell Lines and Exploring Potential as a Treatment for Avian Influenza (Bird Flu) and Other Viruses

Oxidative stress drives aging and is a key factor in diseases like Alzheimer's, Age-related Macular Degeneration (AMD), cardiovascular diseases, cancer, and diabetes. It also plays a critical role in the progression of viral infections, such as avian influenza (bird flu), by exacerbating inflammation and cellular damage. Directly addressing oxidative stress and its consequences is essential to treating the underlying causes of these conditions and mitigating the severity of viral outbreaks.

Orgenesis Secures Up to $5 Million Equity Investment from Williamsburg Venture Holdings

Funding Aimed at Accelerating Rollout of Decentralized CGT Platform

Retransmission: CTT Pharma and Johns Hopkins University Submits Proposal for $15 Million NIH Grant for Smoking Cessation

TAMPA, FL / ACCESS Newswire / January 28, 2025 / CTT Pharmaceutical Holdings, Inc. (OTC:CTTH) and Johns Hopkins University have successfully submitted our proposal for a NIH Grant that will utilize CTT's patented technology as a smoking cessation product. This grant will allow for clinical trials to be conducted and up to $15 million given to cover these trials. The NIH will begin the review process of this proposal in April 2025 and will notify Johns Hopkins University and CTT Pharma of the results. The CEO of CTT Pharma, Ryan Khouri stated, "This brings us one step closer to helping smokers quit, as 480,000 Americans die every year or 1300 per day from the effects of smoking. The last oral nicotine product that was FDA Approved for smoking cessation was Nicorette gum in 1984. While Nicorette gum has helped many people quit smoking, I believe consumers need more options to quit. CTT's fast acting dissolvable nicotine strips would use substantially less nicotine per dose compared to Nicorette Gum and also dissolve in seconds compared to the gum staying in the mouth for 30 minutes. I also want to price our patented technology at or below the price of Nicorette gum, as pricing of our product should not be a deterrent for a consumer looking to quit smoking. Upon approval from the NIH I'm confident in our teams ability to execute our technology and do not anticipate any problems arising. Johns Hopkins University will be in charge of the clinical trials from start to finish. This past October I attended and briefly spoke at a FDA/NIH hearing about advancing smoking cessation technology. I personally met with many individuals who work for both the FDA and NIH and had productive conversations. Furthermore, I have been asked to appear on Fox Business and Bloomberg for interviews in regards to this grant and have interest in doing both shows. I would prefer to do these interviews once our proposal has been approved but I'm considering doing them beforehand. I firmly believe CTT Pharma's dissolvable nicotine strips are a viable solution to a worldwide problem and should be used as a tool to get people to stop smoking." The World Health Organization states, "The tobacco epidemic is one of the biggest public health threats the world has ever faced, killing over 8 million people a year around the world. More than 7 million of those deaths are results of direct tobacco use while 1.3 million are the result of non-smokers being exposed to second-hand smoke." The CDC says, "Cigarette smoking is the leading cause of preventable death in the United States. Cigarette smoking causes more than 480,000 deaths each year in the United States. This is nearly one in five deaths." CTT will continue to update shareholders as more news becomes available.

Distribution Key for Revenues from Centralized Marketing for the 2025/26 to 2028/29 Seasons Adopted by the DFL

DORTMUND, DE / ACCESS Newswire / January 28, 2025 / Yesterday, the Executive Committee of the DFL Deutsche Fußball Liga e.V. unanimously adopted the mechanism for distributing revenue from centralized marketing for the 2025/26 to 2028/29 seasons.

Nigerian extradited, charged over sextortion that led to US teen's death

A Nigerian man has been extradited to the United States to face charges in connection with the sextortion of a teenage boy who subsequently committed suicide.

Frenchman goes on trial for murdering ex-partner after years of abuse

A Frenchman is set to stand trial on Wednesday accused of fatally stabbing his former partner, who had complained of enduring years of abuse and repeatedly reported him to the authorities over his harassment.

Tesla, BMW take EU to court over China EV tariffs

Elon Musk's Tesla and German auto giant BMW have challenged EU import tariffs on China-made electric vehicles at the bloc's top court, the European Commission said Monday.

Two Iranian dissidents at 'imminent risk' of execution: activists

Two Iranian men convicted of membership of the People's Mujahedin opposition group, outlawed by the Islamic republic, are at imminent risk of execution after being transferred to a different prison, the organisation and activists said on Monday.

Japan's Fuji TV bosses resign over sex assault scandal

The chairman and president of Japan's Fuji Television resigned Monday, weeks after a celebrity presenter was accused of sexual assault, causing a public relations storm and the mass exit of advertisers.

Japan's Fuji TV bosses resign over sexual assault scandal

The chairman and president of Japan's Fuji Television resigned Monday, weeks after a celebrity presenter and former pop star was accused of sexual assault.

Bird feathers and bloodstains found in Jeju jet engines: report

Bird feathers and bloodstains were found in both engines of the Jeju Air plane that crashed in December, according to a preliminary investigation released Monday.

Bittersweet return for Syrians with killed, missing relatives

Wafa Mustafa had long dreamed of returning to Syria but the absence of her father tarnished her homecoming more than a decade after he disappeared in Bashar al-Assad's jails.

With Trump win, Silicon Valley's right flank takes on Washington

One week into his second administration, Donald Trump has put technology at the forefront, featuring tech billionaires prominently at his inauguration and announcing major AI infrastructure deals from the White House.

New to the Street Show #623 Airs Tonight on FOX Business at 10:30 PM PST Featuring General Enterprise Ventures (GEVI), AtlasClear, Sustainable Green Team, and DealFlowEvents.com Spotlighting the MicroCap Conference in Atlantic City at the Borgata

New to The Street with host Ana Berry will be interviewing on-site at the Borgata, bringing exclusive insights to our 2.1M loyal YouTube subscribers.

Theralase(R) Interim Clinical Data to be Presented at the 2025 AUA Annual Meeting

TORONTO, ON / ACCESS Newswire / January 27, 2025 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light, radiation, sound and/or drug-activated small molecules and their formulations, intended for the safe and effective destruction of various cancers, bacteria and viruses is proud to announce that its interim clinical data has been selected for presentation at the American Urological Association ("AUA") Annual Meeting.

Appointment of CEO

ORLANDO, FL / ACCESS Newswire / January 27, 2025 / RM2 International, Inc. ("RM2" or the "Company") (OTC Markets:RMTO), a market leader in delivering intelligent customer-focused logistics solutions through trackable composite pallets, announces that industry veteran Wayne Cochran has been promoted to Chief Executive Officer and named a member of the Board of Directors of the Company effective as of January 23, 2025. Mr. Cochran was previously the Chief Operating Officer of RM2. Kevin Mazula, the former CEO of RM2, has stepped down to pursue other activities.

Cosmos Health Submits Patent Application for Allergic Inflammation Therapy by Leveraging AI Drug Repurposing; Allergy Treatment Market Valued at $23.5 Billion

CHICAGO, IL / ACCESS Newswire / January 27, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today the filing of a new patent application for allergic inflammation, a condition characterized by immune system hypersensitivity.

CMSC	-0.53%	20.81	$
RIO	0.42%	103.27	$
RELX	-3.21%	35.51	$
VOD	1.89%	16.9	$
CMSD	-0.34%	20.69	$
RBGPF	0%	70	$
RYCEF	0.7%	19.92	$
NGG	-0.06%	78.12	$
GSK	-1.96%	49.89	$
BTI	-1.12%	55.35	$
JRI	-0.58%	12.14	$
BP	0.52%	43.81	$
BCE	-0.59%	23.67	$
BCC	2.64%	79.21	$
AZN	-1.27%	162.7	$

Arizona Tribune - Boulevard (English)

Featured

Ethiopian Miss World contestant spotlights pain of sister's murder

Nepal tunnel rescue revives hopes 10 days after flood

Last news